Morgans analyst Scott Power said ASX health stocks have fallen for the first week of the 2025 financial year as ...
Vous n'êtes pas connecté
Morgans healthcare analyst Scott Power said ASX health stocks have risen in past five days despite higher than expected inflation ...
Morgans analyst Scott Power said ASX health stocks have fallen for the first week of the 2025 financial year as ...
Consumer discretionary stocks fell sharply after higher-than-expected inflation raised the odds that the Reserve Bank might consider raising rates...
Consumer discretionary stocks fell sharply after higher-than-expected inflation raised the odds that the Reserve Bank might consider raising rates...
Stockbroker Morgans reckons these three ASX tech stocks stand out for being cash earners rather than burners with funds for ...
The ASX edged higher as traders looked ahead to a key US inflation report that could influence the Federal Reserve’s next move on interest rates.
The ASX edged higher as traders looked ahead to a key US inflation report that could influence the Federal Reserve’s next move on interest rates.
Immutep sinks 35pc despite revealing positive topline results for cancer-treatment trial. Investors may have had higher expectations. ...
The Australian sharemarket fell as investors sold energy and healthcare stocks over fresh fears figures to be released this week may show an uptick in...
Stocks in Asia advanced for a second day, following US shares higher, while the Australian dollar advanced on hotter-than-expected inflation.
Iseq index dips amid decline in Irish banking stocks